Drug Development Global Program

Prescription for a healthier world

PATH’s Drug Development program is working to develop and ensure availability and accessibility of safe and effective new medicines for diseases disproportionately affecting people in developing countries. By combining entrepreneurial energy, pharmaceutical expertise, and an innovative product development partnership model, we challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs. Find out more »

Symposium on Innovative Therapeutics Against Cryptosporidium

Symposium on Innovative Therapeutics Against CryptosporidiumPATH hosted this inaugural meeting in San Francisco, California, to help accelerate research and development of needed drugs against Cryptosporidium, a leading cause of diarrheal disease illness and death among young children. Read more»

Program spotlight

in the news: Public-private partnerships critical in fight against infectious diseases »

infographic: A novel route to malaria treatments: Semisynthetic artemisinin »

press release: PATH receives GHIT Fund grant to expand drug research for soil-transmitted helminths »

on our blog: Taking parasitic worms out of childhood »

Sign up for our e-newsletter

Our e-newsletter, A Healthy Dose, gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development. Sign up now »

Banner photo: Jonathan Torgovnik.

Comments are closed.